Key Populations

Self-StudyKey Populations

Sign In or Register to get started

You are just a few steps away from free CE credits!

1

Sign in or Register

A free account is required.

2

Study the Material

An entire Cc section, or just a few topics at a time.

3

Take the CE Quiz

5 questions covering the topics in each Cc section.

4

Claim CE Credit

Free CNE and Free CME available!

loading

New Users

Create a free account to get started.

Required for CE

Returning Users

Forgot password?

Your Certificate of Completion

CE (CNE and CME) Certificates CNE/CME

You can earn CNE or CME for each module in this set. For CNE, your certificate will be provided by the University of Washington School of Nursing. For CME, your certificate will be provided by the University of Alabama at Birmingham. Each of these certificates will reflect the number of modules completed.

Print your CE certificate from the Home screen or one of the modules where you obtained that CE.

 

 

Non-CE Certificate

This certificate only shows the self-study modules you complete and does not show continuing education credits.

Complete Lessons

Each Lesson completed will be displayed on your certificate.
Lesson Quiz completion is required with a minimum score of 80%..

0/8lessons
completed

Print Certificate

Your certificate will show your progress thus far.

Self-Study Module Progress Tracker - 3rd Edition

Lesson 1HIV in Infants and Children
  • Discuss basic epidemiologic features of perinatally-acquired HIV and pediatric HIV in the United States
  • Explain the timing and types of diagnostic tests used to diagnose HIV in infants less than 1 year of age and in older children
  • List symptoms and classification of HIV in children using the most recent CDC surveillance case definition for pediatric HIV
  • Summarize antiretroviral therapy management in children, including initiation, adverse effects, and approach to virologic failure
  • Discuss opportunistic infection prevention recommendations for infants and children and how these recommendations are influenced by a child’s age and stage of HIV
Lesson 2HIV in Adolescents and Young Adults
  • Explain current epidemiologic features of HIV in adolescents and young adults in the United States
  • Discuss factors that increase the risk of adolescents and young adults acquiring HIV 
  • List appropriate antiretroviral regimens for  adolescents and young adults
  • Summarize indications and recommendations for HIV preexposure prophylaxis in adolescents and young adults
  • Describe approaches for successful transition of young adults with HIV into adult primary care HIV practice settings
Lesson 3HIV in Women
  • Describe key epidemiologic features of women with HIV in the United States
  • Summarize contraception options and recommendations for women with HIV
  • Discuss recommended antiretroviral regimens for women who may become pregnant
  • Identify conception strategies for heterosexual HIV-serodifferent couples desiring pregnancy
  • List appropriate steps for evaluation and management of vaginal discharge
Lesson 4HIV in Older Adults
  • Recognize age-related and HIV-related changes to the immune systems of people 50 years of age and older
  • Discuss the interplay of HIV and the aging process within the framework of accelerated and accentuated aging
  • List recommendations for antiretroviral therapy management in persons 50 years of age and older.
  • Explain expected virologic and immunologic responses to antiretroviral therapy in persons 50 years of age and older.
  • Highlight comorbidities that more commonly occur in older adults with HIV
Lesson 5HIV and Corrections
  • Explain the difference between prisons and jails
  • Discuss trends in HIV rates in state and federal prisons
  • List different types of HIV testing practices conducted in correctional facilities
  • Describe issues related to HIV medication administration and adherence within correctional facilities
  • Summarize recommendations for linking persons with HIV to clinical care after release from a correctional facility
Lesson 6HIV in Racial and Ethnic Minority Populations
  • Examine disparities in HIV incidence and prevalence rates among racial/ethnic minority groups in the United States
  • Compare HIV diagnosis rates and care base on race/ethnicity
  • Describe disparities in HIV preexposure prophylaxis (PrEP) coverage among different racial/ethnic groups
  • Identify factors associated with health inequities among racial and ethnic minority populations of persons living with HIV and those at risk for HIV acquisition compared to white populations
  • Summarize strategies for prevention, testing, and care among racial and ethnic minority populations
Lesson 7HIV in Sexual and Gender Minority Populations
  • Contrast HIV prevalence rates among sexual and gender minority populations with those in the general population
  • Describe challenges in health promotion and health care access for sexual and/or gender minority individuals
  • Recognize aspects of care unique to gender and sexual minority persons
  • Summarize unique medical management issues for transgender persons living with HIV who are taking hormone therapy
  • Discuss gender-affirming care in persons with HIV
Lesson 8HIV-2 Infection
  • Contrast HIV-2 and HIV-1 epidemiology, natural history, and pathogenesis
  • Describe diagnostic testing for HIV-2
  • Summarize susceptibility of HIV-2 to antiretroviral medications
  • Discuss antiretroviral treatment recommendations for persons with HIV-2
  • Explain challenges with monitoring after starting antiretroviral therapy for HIV-2
Topic 1 
 
 
 
 
 
 
 
Topic 2 
 
 
 
 
 
 
 
Topic 3 
 
 
 
 
 
 
 
Topic 4 
 
 
 
 
 
 
 
Topic 5 
 
 
 
 
 
 
 
Topic 6 
 
 
 
 
 
 
 
Topic 7 
 
 
 
 
 
 
 
Topic 8 
 
 
 
 
 
 
 
Topic 9 
 
 
 
 
Topic 10 
 
 
Topic 11 
 
Topic 12 
CE Quiz 
 
 
 
 
 
 
 

Self-Study Module Progress Tracker - 2nd Edition

2nd Edition. There is a newer edition of this Self-Study Module.
Lesson 1HIV in Infants and Children
2nd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (2nd).
  • Discuss basic epidemiologic features of perinatally-acquired HIV and pediatric HIV in the United States
  • Explain the timing and types of diagnostic tests used to diagnose HIV in infants less than 1 year of age and in older children
  • List symptoms and classification of HIV in children using the most recent CDC surveillance case definition for pediatric HIV
  • Summarize antiretroviral therapy management in children, including initiation, adverse effects, and approach to virologic failure
  • Discuss opportunistic infection prevention recommendations for infants and children and how these recommendations are influenced by a child’s age and stage of HIV
Lesson 2HIV in Adolescents and Young Adults
2nd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (2nd).
  • Explain current epidemiologic features of HIV in adolescents and young adults in the United States
  • Discuss factors that increase the risk of adolescents and young adults acquiring HIV 
  • List appropriate antiretroviral regimens for  adolescents and young adults
  • Summarize indications and recommendations for HIV preexposure prophylaxis in adolescents and young adults
  • Describe approaches for successful transition of young adults with HIV into adult primary care HIV practice settings
Lesson 3HIV in Women
2nd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (2nd).
  • Describe key epidemiologic features of women with HIV in the United States
  • Summarize contraception options and recommendations for women with HIV
  • Discuss recommended antiretroviral regimens for women who may become pregnant
  • Identify conception strategies for heterosexual HIV-serodifferent couples desiring pregnancy
  • List appropriate steps for evaluation and management of vaginal discharge
Lesson 4HIV in Older Adults
2nd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (2nd).
  • Recognize age-related and HIV-related changes to the immune systems of people 50 years of age and older
  • Summarize cognitive and functional changes that may interfere with adherence to care in people with HIV who are 50 years of age and older
  • List recommendations for antiretroviral therapy management in persons 50 years of age and older.
  • Explain expected virologic and immunologic responses to antiretroviral therapy in persons 50 years of age and older.
  • Discuss common comorbidities of people with HIV who are 50 years of age and older
Lesson 5HIV and Corrections
2nd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (2nd).
  • Explain the difference between prisons and jails
  • Discuss trends in HIV rates in state and federal prisons
  • List different types of HIV testing practices conducted in correctional facilities
  • Describe issues related to HIV medication administration and adherence within correctional facilities
  • Summarize recommendations for linking persons with HIV to clinical care after release from a correctional facility
Lesson 6HIV in Racial and Ethnic Minority Populations
2nd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (2nd).
  • Explain HIV prevalence incidence disparities among different racial and ethnic minority populations in the United States
  • Compare HIV diagnosis rates and care base on race/ethnicity
  • Describe disparities in HIV preexposure prophylaxis (PrEP) coverage among different racial/ethnic groups
  • Identify factors associated with health inequities among racial and ethnic minority populations of persons living with HIV and those at risk for HIV acquisition compared to white populations
  • Summarize strategies for prevention, testing, and care among racial and ethnic minority populations
Lesson 7HIV in Sexual and Gender Minority Populations
2nd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (2nd).
  • Contrast HIV prevalence rates among sexual and gender minority populations with those in the general population
  • Describe challenges in health promotion and health care access for sexual and/or gender minority individuals
  • Recognize aspects of care unique to gender and sexual minority persons
  • Summarize unique medical management issues for transgender persons living with HIV who are taking hormone therapy
  • Discuss gender-affirming care in persons with HIV
Lesson 8HIV-2 Infection
2nd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (2nd).
  • Contrast HIV-2 and HIV-1 epidemiology, natural history, and pathogenesis
  • Describe diagnostic testing for HIV-2
  • Summarize susceptibility of HIV-2 to antiretroviral medications
  • Discuss antiretroviral treatment recommendations for persons with HIV-2
  • Explain challenges with monitoring after starting antiretroviral therapy for HIV-2
Topic 1 
 
 
 
 
 
 
 
Topic 2 
 
 
 
 
 
 
 
Topic 3 
 
 
 
 
 
 
 
Topic 4 
 
 
 
 
 
 
 
Topic 5 
 
 
 
 
 
 
 
Topic 6 
 
 
 
 
 
 
 
Topic 7 
 
 
 
 
 
 
 
Topic 8 
 
 
 
 
 
 
 
Topic 9 
 
 
 
Topic 10 
 
 
Topic 11 
 
Topic 12 
CE Quiz

Self-Study Module Progress Tracker - 1st Edition

1st Edition. There is a newer edition of this Self-Study Module.
Lesson 1HIV in Infants and Children
2nd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (2nd).
  • Discuss basic epidemiologic features of perinatally-acquired HIV and pediatric HIV in the United States
  • Explain the timing and types of diagnostic tests used to diagnose HIV in infants less than 1 year of age and in older children
  • List symptoms and classification of HIV in children using the most recent CDC surveillance case definition for pediatric HIV
  • Summarize antiretroviral therapy management in children, including initiation, adverse effects, and approach to virologic failure
  • Discuss opportunistic infection prevention recommendations for infants and children and how these recommendations are influenced by a child’s age and stage of HIV
Lesson 2HIV in Adolescents and Young Adults
2nd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (2nd).
  • Explain current epidemiologic features of HIV in adolescents and young adults in the United States
  • Discuss factors that increase the risk of adolescents and young adults acquiring HIV 
  • List appropriate antiretroviral regimens for  adolescents and young adults
  • Summarize indications and recommendations for HIV preexposure prophylaxis in adolescents and young adults
  • Describe approaches for successful transition of young adults with HIV into adult primary care HIV practice settings
Lesson 3HIV in Women
2nd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (2nd).
  • Describe key epidemiologic features of women with HIV in the United States
  • Summarize contraception options and recommendations for women with HIV
  • Discuss recommended antiretroviral regimens for women who may become pregnant
  • Identify conception strategies for heterosexual HIV-serodifferent couples desiring pregnancy
  • List appropriate steps for evaluation and management of vaginal discharge
Lesson 4HIV in Older Adults
2nd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (2nd).
  • Recognize age-related and HIV-related changes to the immune systems of people 50 years of age and older
  • Summarize cognitive and functional changes that may interfere with adherence to care in people with HIV who are 50 years of age and older
  • List recommendations for antiretroviral therapy management in persons 50 years of age and older.
  • Explain expected virologic and immunologic responses to antiretroviral therapy in persons 50 years of age and older.
  • Discuss common comorbidities of people with HIV who are 50 years of age and older
Lesson 5HIV and Corrections
2nd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (2nd).
  • Explain the difference between prisons and jails
  • Discuss trends in HIV rates in state and federal prisons
  • List different types of HIV testing practices conducted in correctional facilities
  • Describe issues related to HIV medication administration and adherence within correctional facilities
  • Summarize recommendations for linking persons with HIV to clinical care after release from a correctional facility
Lesson 6HIV in Racial and Ethnic Minority Populations
2nd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (2nd).
  • Explain HIV prevalence incidence disparities among different racial and ethnic minority populations in the United States
  • Compare HIV diagnosis rates and care base on race/ethnicity
  • Describe disparities in HIV preexposure prophylaxis (PrEP) coverage among different racial/ethnic groups
  • Identify factors associated with health inequities among racial and ethnic minority populations of persons living with HIV and those at risk for HIV acquisition compared to white populations
  • Summarize strategies for prevention, testing, and care among racial and ethnic minority populations
Lesson 7HIV in Sexual and Gender Minority Populations
2nd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (2nd).
  • Contrast HIV prevalence rates among sexual and gender minority populations with those in the general population
  • Describe challenges in health promotion and health care access for sexual and/or gender minority individuals
  • Recognize aspects of care unique to gender and sexual minority persons
  • Summarize unique medical management issues for transgender persons living with HIV who are taking hormone therapy
  • Discuss gender-affirming care in persons with HIV
Lesson 8HIV-2 Infection
2nd Edition. There is a newer edition of this Lesson. This is your progress from the previous edition (2nd).
  • Contrast HIV-2 and HIV-1 epidemiology, natural history, and pathogenesis
  • Describe diagnostic testing for HIV-2
  • Summarize susceptibility of HIV-2 to antiretroviral medications
  • Discuss antiretroviral treatment recommendations for persons with HIV-2
  • Explain challenges with monitoring after starting antiretroviral therapy for HIV-2
Topic 1 
 
 
 
 
 
 
 
Topic 2 
 
 
 
 
 
 
 
Topic 3 
 
 
 
 
 
 
 
Topic 4 
 
 
 
 
 
 
 
Topic 5 
 
 
 
 
 
 
 
Topic 6 
 
 
 
 
 
 
 
Topic 7 
 
 
 
 
 
 
 
Topic 8 
 
 
 
 
 
 
 
Topic 9 
 
 
 
Topic 10 
 
 
Topic 11 
 
Topic 12 
CE Quiz

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.